EVIO, Inc. (OTCQB: EVIO) is well-positioned as a leading provider of cannabis analysis and testing in the U.S. An article discussing the company reads: “Operating in one the hottest industries in the marketplace right now, EVIO, Inc. (OTCQB: EVIO) is a life sciences company leading the charge in cannabis analysis and testing. The company currently operates several laboratories throughout the United States—with many more on the horizon—and is a leading provider of accredited cannabis testing, delivering top-quality analytical and consulting services for agricultural and biomedical industries, as well as performing product research. Through its EVIO Labs division, the company offers state-mandated ancillary services to help ensure the quality and safety of the U.S. cannabis supply. …EVIO is on track to open additional labs that will raise its total count to 18 by the end of 2018, and the company has reached this prime position under the guidance of a strong management team composed of business leaders and industry experts.”
To view the full article, visit http://cnw.fm/TBuc9
About EVIO, Inc.
EVIO, Inc. is a life sciences company focused on analyzing cannabis as a means for improving quality of life. The Company provides analytical testing services, advisory services and performs product research in its accredited laboratory testing facilities. The Company’s EVIO Labs division operating coast-to-coast provides state-mandated ancillary services to ensure the safety and quality of the nation’s cannabis supply. For more information, visit www.EvioLabs.com.
More from CannabisNewsBreaks
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
For more information please visit https://www.CannabisNewsWire.com